Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Pure red cell aplasia caused by parvovirus B19 infection in a renal transplant recipient

Pure red cell aplasia caused by parvovirus B19 infection in a renal transplant recipient Pure red cell aplasia caused by parvovirus B19 infection in a renal transplant recipient ~- To the Editor: Human parvovirus B 19, which is the etiologic agent of transient aplastic crisis in hemolytic anemia, is known to cause chronic bone marrow failure in immunocompromised hosts (1-4). To our knowledge, there have been 2 previous case reports describing parvovirus B 19 infection in renal transplant recipients ( 5 , 6 ) . We report here another case of severe anemia caused by parvovirus B 19 infection in a renal transplant recipient. Although humoral immune response to the virus was absent for a while due to immunosuppressive therapy, treatment with a regimen of intravenous commercial immunoglobulin resulted in rapid elevation of the reticulocyte count and resolution of the anemia. A 48-year-old man with chronic renal failure secondary to diabetic nephropathy, who had been undergoing chronic hemodialysis and administration of recombinant human erythropoietin (rhEPO) for the treatment of renal anemia, was hospitalized to receive a cadaveric kidney transplant. On the 1st hospital day (d 0), he underwent cadaver donor kidney transplantation, and immunosuppressive therapy with cyclosporin (3 mg/kg/d), prednisolone (70 mg/d), mizoribine (200 mg/d), and antilymphocyte globulin (1000 mg/d) was started. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Haematology Wiley

Pure red cell aplasia caused by parvovirus B19 infection in a renal transplant recipient

Download PDF
2 pages

Loading next page...
 
/lp/wiley/pure-red-cell-aplasia-caused-by-parvovirus-b19-infection-in-a-renal-ERKpeoeZAM

References (10)

Publisher
Wiley
Copyright
© Munksgaard 1995
ISSN
0902-4441
eISSN
1600-0609
DOI
10.1111/j.1600-0609.1995.tb01634.x
Publisher site
See Article on Publisher Site

Abstract

Pure red cell aplasia caused by parvovirus B19 infection in a renal transplant recipient ~- To the Editor: Human parvovirus B 19, which is the etiologic agent of transient aplastic crisis in hemolytic anemia, is known to cause chronic bone marrow failure in immunocompromised hosts (1-4). To our knowledge, there have been 2 previous case reports describing parvovirus B 19 infection in renal transplant recipients ( 5 , 6 ) . We report here another case of severe anemia caused by parvovirus B 19 infection in a renal transplant recipient. Although humoral immune response to the virus was absent for a while due to immunosuppressive therapy, treatment with a regimen of intravenous commercial immunoglobulin resulted in rapid elevation of the reticulocyte count and resolution of the anemia. A 48-year-old man with chronic renal failure secondary to diabetic nephropathy, who had been undergoing chronic hemodialysis and administration of recombinant human erythropoietin (rhEPO) for the treatment of renal anemia, was hospitalized to receive a cadaveric kidney transplant. On the 1st hospital day (d 0), he underwent cadaver donor kidney transplantation, and immunosuppressive therapy with cyclosporin (3 mg/kg/d), prednisolone (70 mg/d), mizoribine (200 mg/d), and antilymphocyte globulin (1000 mg/d) was started.

Journal

European Journal of Haematology – Wiley

Published: Jan 1, 1995

There are no references for this article.